Le Lézard
Classified in: Health, Science and technology
Subject: PER

Litmus Health Cofounder and Chief Scientific Officer Appointed as Chairman of the Clinical Research Data Sharing Alliance


Dr. Samuel Volchenboum to lead organizational push to accelerate drug discovery and development

NEW YORK, May 30, 2023 /PRNewswire-PRWeb/ -- Litmus Health, the research-ready infrastructure platform for wearables and sensor data, today announced that Cofounder and Chief Scientific Officer Dr. Samuel Volchenboum has been appointed as chairman of the Clinical Research Data Sharing Alliance (CRDSA). In his role, Dr. Volchenboum will lead the organization's board of directors in maximizing the strategic impact of the organization in its push to accelerate drug discovery through the use of high-quality data in the clinical trials process.

Since its founding in 2021, the CRDSA has been focused on serving the clinical data sharing ecosystem by addressing the challenges in the life sciences data sharing ecosystem. Some of the biggest issues are rooted in inconsistent data standards and lack of best practices. With an unprecedented amount of data available to clinical researchers ? including relatively new data sources like wearables and sensors ? addressing these challenges has never been more pressing. The growing clinical trial software market alone speaks to the tremendous opportunity that lies in maximizing the usability and interoperability of trial data.

"The advancements in data collection and applications over the past decade have presented a tremendous opportunity to rapidly accelerate drug discovery, but there are critical challenges that must be addressed to make the most of these advancements," said Dr. Volchenboum. "The lack of current data best practices ? especially in regards to standards and sharing ? means that valuable life-saving insights are locked away in data that is difficult or impossible to use. The CRDSA is addressing these problems head-on by bringing together the best minds from the public and private sectors to develop actionable solutions. I am honored to be serving as chairperson of the organization's board of directors."

In addition to serving as Cofounder and Chief Scientific Officer to Litmus Health, Dr. Volchenboum currently serves as Director of Data for the Common Good and their flagship project, the Pediatric Data Commons at the University of Chicago. With his extensive experience in developing clinical research protocols, Dr. Volchenboum is uniquely positioned to lead the CRDSA board and help establish standards for the industry's future.

To learn more about the CRDSA and its mission, visit crdsalliance.org. To learn more about how Dr. Volchenboum and Litmus Health are working to provide end-to-end solutions for clinical trial data capture, monitoring, and analysis, visit litmushealth.com.

About Litmus Health

Litmus Health provides end-to-end solutions for clinical trial data capture, monitoring, and analysis. We are research-ready infrastructure for wearables and sensor data. Our goal is to help researchers increase the certainty of their conclusions and describe the full value of their digital clinical trials.

To learn more, visit litmushealth.com.

Media Contact

Heather Stafford, JDI, Inc, 443-848-8617, [email protected]

 

SOURCE Litmus Health


These press releases may also interest you

at 14:00
Neuroscientists have established in recent decades the idea that some of each day's experiences are converted by the brain into permanent memories during sleep the same night. Now, a new study proposes a mechanism that determines which memories are...

at 14:00
While traditional diaper rash creams are thick, sticky, and messy, Taro's new bébé Bottoms Diaper Rash Crème Spray allows for easy, one-handed application of a gentle spray formula that is touch-free with no rubbing needed. The light spray, which...

at 13:55
An expert panel has published the first performance measures to identify remission and evaluate the effectiveness of lifestyle medicine treatments, which will allow more objective comparisons between lifestyle behavior interventions and other...

at 13:51
BRIJ Medical proudly welcomes three distinguished industry leaders to its Board of Directors: John Grotting, Bob Zollars, and Jim Hinrichs. Leveraging their extensive experience and insights, they will steer the company's strategic vision and drive...

at 13:47
Everyone deserves to succeed. But today, for too many Canadians, your hard work isn't paying off like it did for previous generations. Your paycheque doesn't go as far as costs go up, and saving enough to go after your dreams seems harder and harder....

at 13:41
With sadness, AAD announced today that its influential board member and investor James Herbert has died following a lengthy battle with cancer. He was 83....



News published on and distributed by: